Management of atrial fibrillation

Pasquale Vergara; Paolo Della Bella

doi:10.12703/P6-22

Management of atrial fibrillation

Pasquale Vergara, Paolo Della Bella

IRCCS Ospedale San Raffaele

Research output: Contribution to journal › Article › peer-review

Abstract

Atrial fibrillation (AF) is associated with increases in the risk of mortality, congestive heart failure, and stroke. Medical treatment is aimed at preventing thrombo-embolic complications and reducing symptoms and consequences related to the arrhythmia. In the first section of this review, we discuss the principles of mainstream oral anticoagulant therapy and the possible advantages of the new oral anticoagulants. In the second section, we review the catheter ablation approaches to paroxysmal and persistent/long-standing AF, their results, and the current application of new catheters.

Original language	English
Article number	22
Journal	F1000Prime Reports
Volume	6
DOIs	https://doi.org/10.12703/P6-22
Publication status	Published - Apr 1 2014

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.12703/P6-22

Cite this

@article{0717e981e5af48dbb77ed8529a238acc,

title = "Management of atrial fibrillation",

abstract = "Atrial fibrillation (AF) is associated with increases in the risk of mortality, congestive heart failure, and stroke. Medical treatment is aimed at preventing thrombo-embolic complications and reducing symptoms and consequences related to the arrhythmia. In the first section of this review, we discuss the principles of mainstream oral anticoagulant therapy and the possible advantages of the new oral anticoagulants. In the second section, we review the catheter ablation approaches to paroxysmal and persistent/long-standing AF, their results, and the current application of new catheters.",

author = "Pasquale Vergara and {Della Bella}, Paolo",

year = "2014",

month = apr,

day = "1",

doi = "10.12703/P6-22",

language = "English",

volume = "6",

journal = "F1000Prime Reports",

issn = "2051-7599",

publisher = "Faculty of 1000 Ltd",

}

TY - JOUR

T1 - Management of atrial fibrillation

AU - Vergara, Pasquale

AU - Della Bella, Paolo

PY - 2014/4/1

Y1 - 2014/4/1

N2 - Atrial fibrillation (AF) is associated with increases in the risk of mortality, congestive heart failure, and stroke. Medical treatment is aimed at preventing thrombo-embolic complications and reducing symptoms and consequences related to the arrhythmia. In the first section of this review, we discuss the principles of mainstream oral anticoagulant therapy and the possible advantages of the new oral anticoagulants. In the second section, we review the catheter ablation approaches to paroxysmal and persistent/long-standing AF, their results, and the current application of new catheters.

AB - Atrial fibrillation (AF) is associated with increases in the risk of mortality, congestive heart failure, and stroke. Medical treatment is aimed at preventing thrombo-embolic complications and reducing symptoms and consequences related to the arrhythmia. In the first section of this review, we discuss the principles of mainstream oral anticoagulant therapy and the possible advantages of the new oral anticoagulants. In the second section, we review the catheter ablation approaches to paroxysmal and persistent/long-standing AF, their results, and the current application of new catheters.

UR - http://www.scopus.com/inward/record.url?scp=84899759896&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899759896&partnerID=8YFLogxK

U2 - 10.12703/P6-22

DO - 10.12703/P6-22

M3 - Article

AN - SCOPUS:84899759896

SN - 2051-7599

VL - 6

JO - F1000Prime Reports

JF - F1000Prime Reports

M1 - 22

ER -

Management of atrial fibrillation

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this